COVID-19 Alert Due to the coronavirus (COVID-19), Event/Conference Details may be Updated. Please Confirm Event/Conference details with event organisers.

Event Promotional Campaigns

Event Type - Conference

10 Dec 2019

11 Dec 2019


Glioblastoma Drug Development Summit 2019     (354 Views)     

Event Serial No.-  WLD135945
Contact Person - Customer Services
Event inquiry /Organizer email address -
Deadline for abstracts/proposals: 2019-12-09
Organized by: Hanson Wade View more Conference
Topic Covered: Oncology Oncology ,

The Westin Boston Waterfront Hotel,  425 Summer Street, Boston, 02210,  United States of America

About Event

Accelerate the Discovery, Translation & Clinical Development of Safe, Effective & Deliverable Therapies to Patients in Need This December, 60 thought-leaders including neuro-oncologists, neurosurgeons and oncology professionals from biopharma will be converging at the first industry led Glioblastoma Drug Development Summit under a common goal of accelerating the practical discovery, translation and clinical development of safe, effective and deliverable therapies to treat glioblastoma. Time: 08:30 - 18:00 Price: Industry : USD 2699.0, Academic : USD 1699.0 Speakers: Adilia Hormigo, Director Neuro-Oncology Division, Icahn School of Medicine , Mount Sinai & The Tisch Cancer Institute, Antonio Chiocca , Neurosurgeon-in-chief & Chairman, Brigham & Women’s, Christophe Quéva , Chief Scientific Officer, Oncorus, David Nathanson, Assistant Professor, UCLA, Douglas Jolly, Executive VP, Tocagen, Ed Reilly, Distinguished Research Fellow, AbbVie, James Garner, Chief Executive Officer & Managing Director, Kazia Therapeutics Limited, James Stuart , Medical Director, Innovate Pharmaceuticals, Jann Sarkaria , Professor of Radiation Oncology, Mayo Clinic, Jeffrey Skolnik, Vice President, Inovio Pharmaceuticals, Kirk Tanner, Chief Scientific Officer, National Brain Tumor Society NBTS, Laurent Salphati, Principal Scientist, Genentech, Marnix Bosch, CTO, Northwest Biotherapeutics, Patrick Wen Director, Center For Neuro-Oncology, Dana-FarberBrigham & Women’s Cancer Center, Ranjit S. Bindra, Associate Professor of Therapeutic Radiology, Yale School of Medicine, Sharon Shacham, President & Chief Scientific Officer Co-founder, Karyopharm, Stephen Durant, Associate Principal Scientist, AstraZeneca, Susan Chang, Director, UCSF, Thomas N. Seyfried, Professor, Boston College, Timothy Cloughesy, Director, Neuro-Oncology Program, Professor UCLA, William F. Elmquist, Professor and Director of the Brain Barriers Research Center, University of Minnesota, Michael Lim, Director of the Brain Tumor Immunotherapy Program, Johns Hopkins University School of Medicine, Josep Garcia, Global Development Lead for Avastin, Roche-Genentech, Speaker to be Announced, GBM Agile Global Coalition for Adaptive Research
For Custom Banner please send mail Along with banner image (width 1200px Height 300px) and event serial no.

Important Updates : Past Conference Highlights

Please share your conference videos and photos we will publish it in our youtube channel , past conference highlight page, also in our social pages ,
So that Organizer will get extra benefit to upcoming conferences.

What to share
1 . Photos
2 . Videos
3 . Coference Detail (Conference Name, Conference Date, Conference Detail ,Place,Organizer Detail ,Conference Highlight & Description)
4. Also subscribe to our youtube channel (

Share By Using

Whats App No. +91 8374094855
Or By Email -